Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS) [EARLY_Phase 1]

View source ↗

Summary

An early-stage 1 clinical trial evaluating psilocybin-assisted psychotherapy for irritable bowel syndrome is described, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: NYU Langone Health | Conditions: IBS - Irritable Bowel Syndrome | EARLY_Phase 1 | Status: NOT_YET_RECRUITING